1 / 2

Smoking Cessation

The research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Number R43AI106188. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.<br>

aradigm
Download Presentation

Smoking Cessation

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. February 27, 2015 Aradigm Corporation President & CEO Dr. Igor Gonda, Ph.D. to Be Interviewed Live on iHeart Radio/ Clear Channel Atlanta Studios - 640 WGST AM's "Health Tech Talk Live" Live Interview to Air on February 28th, 2015, Hosted by Ben Chodor, 3:00pm ET/12:00pm PT/2:00pm CT HAYWARD, CA -- (Marketwired) -- 02/27/15 -- Aradigm Corporation (NASDAQ: ARDM), a company actively engaged in fulfilling the promise of developing inhalation drug products that could revolutionize the quality of life of patients with severe pulmonary disease, announced today that President and Chief Executive Officer (CEO) Dr. Igor Gonda, Ph.D. will be interviewed live on iHeart Radio's Health Tech Talk Live hosted by Ben Chodor and broadcasted nationwide on iHeart Radio/ Clear Channel Atlanta Studios - 640 WGST AM tomorrow, at 3:00pm ET. In this exclusive double-segment interview, Dr. Gonda will discuss how the company has attracted an outstanding team of scientists, engineers and clinical experts who have been at the forefront of development of advanced inhalation delivery products like AERx®, a pulmonary delivery platform. Shareholders, analysts, industry professionals and all interested parties are encouraged to listen live via Clear Channel's nationally syndicated iHeart Radio stream. Date: February 28, 2015 Start Time: 3:00pm ET | 12:00pm PT | 2:00pm CT (U.S.) Network: iHeart Radio/ Clear Channel Station: 640 WGST AM Show: Health Tech Talk Live Host: Ben Chodor iHeart Radio Live Stream:CLICK HERE About Aradigm Corporation Aradigm is actively engaged in fulfilling the promise of developing inhalation drug products that could revolutionize the quality of life of patients with severe pulmonary disease. Since 1991, the company has attracted an outstanding team of scientists, engineers and clinical experts who have been at the forefront of development of advanced inhalation delivery products. This team for example, pioneered the AERx® pulmonary delivery platform that was tested in thousands of patients with drugs and biologics including insulin, fentanyl, erythropoietin and nicotine. With the depth of experience and expertise in inhalation delivery, Aradigm is uniquely positioned to develop a portfolio of its own products to treat patients with severe respiratory diseases. The current pipeline includes an inhaled antibiotic being developed for the treatment of bronchiectasis*, cystic fibrosis and for biodefense, and inhaled nicotine for smoking cessation. About President and CEO Dr. Igor Gonda, Ph.D. Dr. Gonda has served as President and Chief Executive Officer since August 2006, and as a director since September 2001. From December 2001 to August 2006, Dr. Gonda was the Chief Executive Officer and Managing Director of Acrux Limited, a publicly traded specialty pharmaceutical company located in Melbourne, Australia. From July 2001 to December 2001, Dr. Gonda was our Chief Scientific Officer and, from October 1995 to July 2001, was our Vice President, Research and Development. From February 1992 to September 1995, Dr. Gonda was a Senior Scientist and Group Leader at Genentech, Inc. leading inhalation development of products for severe respiratory disease. Prior to that, Dr. Gonda held academic positions at the University of Aston in Birmingham, United Kingdom, and the University of Sydney, Australia. Dr. Gonda holds a B.Sc. in Chemistry and a Ph.D. in Physical Chemistry from Leeds University, United Kingdom. Dr. Gonda was the Chairman of our Scientific Advisory Board until August 2006. About iHeart Radio/ Clear Channel Clear Channel's Media and Entertainment division has the largest reach of any radio or television outlet in America with 243 million monthly listeners. It serves 150 cities through 850 owned radio stations in the U.S., as well as more than 140 stations in New Zealand and Australia. For more Information Visit: http://www.iheart.com/live/talk-radio-640-wgst-6066/? autoplay=true&pname=15153&campid=play_bar&cid=main.html. About Health Tech Talk Live Health Tech Talk Live broadcasts live weekly on iHeart Radio / Clear Channel nationwide from 640 WGST AM Atlanta, 3:00pm - 4:00pm EST every Saturday. Host Ben Chodor interviews the front-page emerging health tech innovators and titans about the latest in digital health technology, human ingenuity, bio-tech medical advancements and health tech capital market trends.

  2. Learn how the experts use risk management techniques and clinical trials to build fully diversified portfolios and what it takes to put up big board earnings from making people healthier. It's a fast moving, high-energy show... shift your thinking and join us as we deliver "tomorrow's ideas today" on iHeart Radio and Clear Channel's Health Tech Talk Live. Visit iHeart Radio's HealthTech Talk Radio Show or visit www.HealthTechTalk.com. If you're interested in being a guest on Health Tech Talk Live radio show, please contact 1800PublicRelations at support@1800pr.com "ATTN: Health Tech Talk Guest Inquiry." A 1800PublicRelations.com PR Event... Company Contact: Aradigm Corporation 3929 Point Eden Way Hayward, CA 94545 510-265-9000 www.aradigm.com Interview Press/ Media Contact: Matthew BIRD President 1-800-PublicRelations, Inc. 917.409.8211 matt.bird@1800pr.com www.1800pr.com Source: Aradigm Corporation News Provided by Acquire Media

More Related